SEC Form 4 · accession 0001209191-17-041385
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven H Stein
Officer — EVP & Chief Medical Officer
Period of report
Jun 20, 2017
Accepted (ET)
Jun 22, 2017 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 20, 2017 | M | 3,870 | $95.76 | A | 18,518 | D | |
| Common Stock | Jun 20, 2017 | M | 6,013 | $88.68 | A | 24,531 | D | |
| Common StockF1 | Jun 20, 2017 | S | 3,870 | $125.00 | D | 20,661 | D | |
| Common StockF1,F2 | Jun 20, 2017 | S | 6,013 | $125.00 | D | 14,648 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $95.76 | Jun 20, 2017 | M | 3,870 | D | — | Jan 6, 2023 | Common Stock | 3,870 | 9,392 | D |
| Non-Qualified Stock Option (right to buy)F4 | $88.68 | Jun 20, 2017 | M | 6,013 | D | — | Mar 1, 2022 | Common Stock | 6,013 | 9,878 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- F2This includes an 14,648 aggregate of shares of common stock issuable pursuant to previously reported restricted stock units that have not vested
- F3Beginning January 7, 2016, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years
- F4Beginning March 2, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.